|
Home
About Us
Services
Experts
How to Join
Resources
Careers
Contact
| |
Our Value-Add
Nitron offers one of the few proven means to improve your returns
in a hyper-efficient marketplace: direct insight from thought leaders and
practitioners in the industries that you follow. We identify the well-connected
frontline experts in the industries that you follow. We take care of recruiting,
negotiating, and paying these experts.
We are a trusted independent third party in the new world order
of Wall Street.
We can add far more value to your research process than
traditional research:
-
Our only role is to quickly connect you with the most appropriate and insightful
experts. We do not manage money and have no investment banking business.
-
You get information direct from the source, rather than getting information
through two, three or even four intermediaries all of which can trade ahead of
you.
-
Taking into account the quality of our leading experts and our ability to
quickly connect you with our network , we are far cheaper than the alternative.
Management
David Teten, CEO
David Teten was formerly CEO of
Teten Advisors, an integrated advisory firm for small and
mid-cap growth businesses. Previously, he was CEO of an internet investment bank which he built to over 450
clients, focusing on serving the internet domain name asset class. He worked with Bear Stearns’ Investment Banking
division as a member of their technology/defense mergers and acquisitions
team. While a strategy consultant
with Mars & Co, he lived and worked in Brazil and the US. He has also worked
for Procter & Gamble and Foote, Cone & Belding. He ran an independent advertising agency
and built a computer consulting group which served over 35
clients. David holds a Harvard MBA with Second Year Honors and a Yale BA with
Distinction in Psychology. He has also lived and worked in Israel, France, and
Taiwan.
David is a frequent public speaker. He has
presented to (among others): The Wharton School MBA
Program; Columbia Business School;
Princeton Alumni New York Networking Group; the New York Society of Security Analysts; and ExecuNet. He is currently
writing a book on online
business networking.
Albert Sebag, Ph.D., JD, Managing Director
Dr. Sebag began his career as a chemist developing
anti-cancer drugs. Following that, he completed law school and joined Kenyon &
Kenyon’s patent litigation team. His responsibilities there centered on advising
and representing generic drug companies in biotechnology and pharmaceutical
litigations. Some of these litigations concerned generic versions of Nabumetone®,
Paroxetine®, Loratidine®, and other drugs. Dr. Sebag is the founder and Chairman
of Cancer Advisors, a leading oncology
information company, staffed by oncologists, which matches hundreds of cancer
patients to clinical trials each year. He consults for pharmaceutical and biotechnology companies on drug
development, FDA regulatory issues, and patent law. He earned his Ph.D. in
bioorganic chemistry at Northeastern University, conducted research at MIT, and
completed his J.D. at Boston College.
Nicole Chong, Vice President, Business
Development
Ms. Chong previously served as a Group Director of Strategy and Business
Development at The New York Times Company. She has also worked with Eli Lilly
and Company in strategic marketing, and The New England Journal of Medicine.
Ms. Chong has an M.B.A. in Marketing from The Wharton School, and a B.A. in
English cum laude from
Wellesley College.
|
